• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHROCARE CORP. SINU FOAM; SPLINT, INTRANASAL SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHROCARE CORP. SINU FOAM; SPLINT, INTRANASAL SEPTAL Back to Search Results
Catalog Number RR 650
Device Problems Device Ingredient or Reagent Problem (2910); Appropriate Term/Code Not Available (3191)
Patient Problem Unspecified Infection (1930)
Event Date 02/17/2017
Event Type  Injury  
Event Description
It was reported that sinufoam stayed in the maxillary sinuses for 4-6 months causing an infection that required revision surgery.
 
Manufacturer Narrative
Visual inspection and functional testing could not be performed because the product in question was not returned for evaluation.Thus, the customer¿s complaint could not be verified, nor could a root cause be determined with confidence.It is possible the product was not sufficiently hydrated with lactated ringer solution or water, which could delay the timeline for product dissolution.It is also possible the patient did not irrigate properly after implantation.The instructions for use (ifu) provided with the device contains warnings and precautionary measures related to proper use of the device including but not limited to: - have the patient irrigate with light isotonic saline solution (0.65%) until first office visit (do not irrigate with hypertonic saline solution or bulb style syringe until after first office visit).- any residual dressing that has not dissolved or left the surgical site through normal outflow passages may be easily aspirated at the discretion of the surgeon.There were no indications during manufacturing record review that would suggest the product did not meet product specifications upon release into distribution.
 
Event Description
It was reported that, after a sinus procedure, sinufoam stayed in the maxillary sinuses for 5 months causing a severe infection that required bilateral sinus revision surgery.All the material was washed out.Patient was prescribed sinus rinses with surfactant to remove biofilm effect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SINU FOAM
Type of Device
SPLINT, INTRANASAL SEPTAL
Manufacturer (Section D)
ARTHROCARE CORP.
7000 w. william cannon
austin TX 78735
Manufacturer (Section G)
ARTHROCARE CORP.
7000 w. william cannon
austin TX 78735
Manufacturer Contact
holly topping
7000 w. william cannon
austin, TX 78735
5123913905
MDR Report Key6594138
MDR Text Key76060465
Report Number3006524618-2017-00133
Device Sequence Number1
Product Code LYA
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/01/2017
Device Catalogue NumberRR 650
Device Lot Number4100203
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/30/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age42 YR
Patient SexFemale
-
-